glp 1 in type 1 diabetes for weight loss More people with are using GLP-1 drugs, study finds, despite limited evidence on safety or effectiveness GLP-1 Agonists For Obesity In

W., van der Voorn, B., Iyer, A

, they found that the response in the early phase of the trial, could predict the therapeutic benefit after a follow-up of six months ( Good candidates for eluxadoline (second-line) Women and men with moderate IBS-D, and both abdominal pain and diarrhea as predominant symptoms, after loperamide failure and without any contraindication (cholecystectomy, biliary duct obstruction, pancreatitis, hepatic impairment, alcohol abuse, and chronic or severe constipation)

US FDA approves first drug for sickle-cell anaemia

Theyre all the rage! As always, there is a grain of legitimacy inside this story, but that grain has been puffed and roasted beyond recognition